Source: ALL
| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RAS p21 protein activator 1 | 0.481 | 0.885 | 1.00 |
|
disease | 0.500 | None | 0.846 | 13 | 0 | 2003 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.120 | None | 1.000 | 2 | 2 | 2005 | 2017 | ||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
disease | 0.120 | None | 1.000 | 2 | 0 | 2017 | 2018 | ||||||||
|
TEK receptor tyrosine kinase | 0.462 | 0.692 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
activin A receptor like type 1 | 0.493 | 0.769 | 9.7E-04 |
|
disease | 0.100 | None | 0.977 | 43 | 0 | 2000 | 2020 | ||||||||
|
endoglin | 0.446 | 0.846 | 1.00 |
|
disease | 0.100 | None | 1.000 | 43 | 2 | 1996 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1996 | 2020 | ||||||||
|
secretory leukocyte peptidase inhibitor | 0.449 | 0.846 | 9.0E-04 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 2005 | 2019 | ||||||||
|
FA complementation group D2 | 0.479 | 0.885 | 1.1E-30 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group E | 0.553 | 0.808 | 1.5E-06 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group B | 0.468 | 0.769 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group F | 0.535 | 0.731 | 0.46 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
recombination signal binding protein for immunoglobulin kappa J region | 0.518 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
FA complementation group M | 0.543 | 0.731 | 2.4E-15 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ring finger and WD repeat domain 3 | 0.569 | 0.731 | 3.5E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
motor neuron and pancreas homeobox 1 | 0.555 | 0.615 | 0.79 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
glucuronidase beta | 0.530 | 0.846 | 4.0E-08 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ubiquitin conjugating enzyme E2 T | 0.550 | 0.731 | 1.1E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
EGF domain specific O-linked N-acetylglucosamine transferase | 0.641 | 0.500 | 5.0E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
G protein subunit alpha q | 0.516 | 0.808 | 0.98 |
|
disease | 0.100 | None | 0 | 0 |